MacroGenics (MGNX) SEC Filings & 10K Form

$16.05
-0.32 (-1.95%)
(As of 05/7/2024 ET)

Recent MacroGenics SEC Filings

DateFilerForm TypeView
04/08/2024
5:07 PM
MacroGenics (Issuer)
Peters Jeffrey Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:31 PM
MacroGenics (Filer)
Form DEF 14A
04/08/2024
3:32 PM
MacroGenics (Filer)
Form DEFA14A
04/08/2024
3:33 PM
MacroGenics (Filer)
Form ARS
04/04/2024
3:57 PM
MacroGenics (Subject)
Peters Jeffrey Stuart (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
4:24 PM
MacroGenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
3:16 PM
MacroGenics (Subject)
Peters Jeffrey Stuart (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:18 PM
Karrels James (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:19 PM
MacroGenics (Issuer)
Spitznagel Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
MacroGenics (Issuer)
Risser Eric Blasius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:46 PM
MacroGenics (Subject)
Spitznagel Thomas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
4:39 PM
MacroGenics (Subject)
Risser Eric Blasius (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
5:41 PM
Eck Stephen L. (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:03 PM
Bonvini Ezio (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:03 PM
MacroGenics (Issuer)
Spitznagel Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:04 PM
Karrels James (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:04 PM
MacroGenics (Issuer)
Risser Eric Blasius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:04 PM
Cilinski Lynn (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:04 PM
Koenig Scott (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:05 PM
MacroGenics (Issuer)
Peters Jeffrey Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:29 PM
ARMISTICE CAPITAL, LLC (Filed by)
MacroGenics (Subject)
Form SC 13G/A
02/13/2024
5:13 AM
BB BIOTECH AG (Filed by)
MacroGenics (Subject)
Form SC 13G/A
02/12/2024
4:31 PM
Eck Stephen L. (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:31 PM
Karrels James (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:31 PM
Koenig Scott (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:32 PM
MacroGenics (Issuer)
Peters Jeffrey Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:32 PM
MacroGenics (Issuer)
Risser Eric Blasius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:32 PM
Bonvini Ezio (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:32 PM
MacroGenics (Issuer)
Spitznagel Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:32 PM
Cilinski Lynn (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
3:17 PM
MacroGenics (Issuer)
Peters Jeffrey Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
3:19 PM
Bonvini Ezio (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
3:21 PM
Bonvini Ezio (Reporting)
MacroGenics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:08 PM
MacroGenics (Subject)
Peters Jeffrey Stuart (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:21 PM
Bonvini Ezio (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
MacroGenics (Subject)
Form SC 13G/A
01/22/2024
3:57 PM
Bonvini Ezio (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:02 PM
Bonvini Ezio (Reporting)
MacroGenics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
4:11 PM
Bonvini Ezio (Reporting)
MacroGenics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2023
11:15 PM
MacroGenics (Filer)
Form EFFECT
11/06/2023
3:03 PM
MacroGenics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Elon to Transform U.S. Economy? (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.
11/06/2023
3:04 PM
MacroGenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
3:09 PM
MacroGenics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/30/2023
3:45 PM
MacroGenics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
10/04/2023
2:31 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:42 PM
MacroGenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
2:39 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
7:39 AM
MacroGenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MGNX) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners